Please assess the completion status of the following clinical trial:

Trial Title: Local Phase 4 Pan-European SMART Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients at out-patient clinics~* \>18 years with a minimum of 6 months documented history of persistent asthma who have used inhaled glucocorticosteroids for at least one month and have a history of use in rapid-acting B2 agonists for symptom relief~Exclusion Criteria:~* Asthma exacerbation within the last 14 days prior to study start~* subject aged \>40 years with a smoking history of \>10pack-years~* subjects with chronic obstructive lung disease or other significant respiratory disease

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).